subscribeSubscribe
Enforcement Report - Week of March 1, 2023

Enforcement Report - Week of March 1, 2023
FDA
01 Mar 2023
Share Share
Boehringer says Pradaxa found to be safe for recurrent VTE prevention

Boehringer says Pradaxa found to be safe for recurrent VTE prevention
CLINICALTRIALSARENA
03 Sep 2019
Share Share
Warfarin Monitors: FDA Warns of Inaccurate Results

Warfarin Monitors: FDA Warns of Inaccurate Results
Zach Brennan RAPS
04 Nov 2018
Share Share
Swedish Bt targeting thrombosis using body’s own defense system to prevent clots

Swedish Bt targeting thrombosis using body’s own defense system to prevent clots
Jonas Söderström ENDPTS
01 Oct 2018
Share Share
You Should Not Miss Bristol-Myers Squibb In 2018

You Should Not Miss Bristol-Myers Squibb In 2018
SEEKING ALPHA
10 Aug 2018
Share Share
Many at risk for stroke don’t get anti-clotting drugs

Many at risk for stroke don’t get anti-clotting drugs
Lisa Rapaport REUTERS
15 Mar 2017
Share Share
Cadila Healthcare Limited receives warning letter due to cGMP deviations

Cadila Healthcare Limited receives warning letter due to cGMP deviations

FDA
31 Dec 2015
Share Share
New cardiovascular drugs raise concerns about pricing, efficacy

New cardiovascular drugs raise concerns about pricing, efficacy
MMM
21 Dec 2015
Share Share
Popular Blood Thinner Causing Deaths, Injuries at Nursing Homes

Popular Blood Thinner Causing Deaths, Injuries at Nursing Homes
Charles Ornstein PROPUBLICA
14 Jul 2015
Share Share
FDA gives Boehringer`s Pradaxa antidote a boost with fast-track review

FDA gives Boehringer`s Pradaxa antidote a boost with fast-track review
Tracy Staton FIERCE PHARMA
23 Apr 2015
Share Share